Effect Of Acetazolamide On Altitude Related Illness In Patients With Respiratory Disease
Status:
Completed
Trial end date:
2018-08-02
Target enrollment:
Participant gender:
Summary
Randomized, placebo controlled trial evaluating efficacy of acetazolamide in preventing
altitude related adverse health effects (ARAHE) in lowlanders with chronic obstructive lung
disease travelling from 760 m to 3200 m.
Phase:
Phase 4
Details
Lead Sponsor:
University of Zurich
Collaborator:
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov